J. Emerson, M. Rosenfeld, S. Mcnamara, R. B. Gibson, and R. , Pseudomonas aeruginosa 313 and other predictors of mortality and morbidity in young children with cystic fibrosis

R. Henry, C. Mellis, and L. Petrovic, MucoidPseudomonas aeruginosa is a marker of poor survival in cystic fibrosis, Pediatric Pulmonology, vol.96, issue.3, pp.158-161, 1992.
DOI : 10.1001/archpedi.1958.02060060008002

N. Hoiby, Recent advances in the treatment of Pseudomonas aeruginosainfections in cystic fibrosis, BMC Medicine, vol.6, issue.suppl. 33, p.32, 2011.
DOI : 10.1016/j.jcf.2007.02.001

C. Hansen, T. Pressler, and N. Hoiby, Early aggressive eradication therapy for intermittent Pseudomonas aeruginosa airway colonization in cystic fibrosis patients: 15??years experience, Journal of Cystic Fibrosis, vol.7, issue.6, pp.523-530, 2008.
DOI : 10.1016/j.jcf.2008.06.009

P. Croughs, B. Li, J. Hoogkamp-korstanje, and E. Stobberingh, Thirteen years of antibiotic susceptibility surveillance of Pseudomonas aeruginosa from intensive care units and urology services in the Netherlands, European Journal of Clinical Microbiology & Infectious Diseases, vol.54, issue.11, pp.283-288, 2013.
DOI : 10.1007/s10096-012-1741-4

A. Reyes, M. Haynes, and N. Hanson, Viruses in the faecal microbiota of monozygotic twins and their mothers, Nature, vol.11, issue.7304, pp.334-338, 2010.
DOI : 10.1038/nature09199

F. Rodriguez-valera, A. Martin-cuadrado, and B. Rodriguez-brito, Explaining microbial population genomics through phage predation, Nature Reviews Microbiology, vol.62, issue.11, pp.828-836, 2009.
DOI : 10.1101/SQB.1951.016.01.026
URL : http://doi.org/10.1038/npre.2009.3489

P. Gomez and A. Buckling, Bacteria-Phage Antagonistic Coevolution in Soil, Science, vol.21, issue.3, pp.106-109, 2011.
DOI : 10.1111/j.1420-9101.2008.01501.x

R. Matos, N. Lapaque, and L. Rigottier-gois, Enterococcus faecalis Prophage Dynamics and Contributions to Pathogenic Traits, PLoS Genetics, vol.7, issue.6, p.1003539, 2013.
DOI : 10.1371/journal.pgen.1003539.s007
URL : https://hal.archives-ouvertes.fr/hal-01190746

J. Barr, R. Auro, and M. Furlan, Bacteriophage adhering to mucus provide a non-host-derived immunity, Proceedings of the National Academy of Sciences, vol.66, issue.12, pp.10771-10776, 2013.
DOI : 10.1016/0022-2836(89)90464-6
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696810

F. 11-d-'herelle, Sur un microbe invisible antagoniste des bacilles dysentériques. Les Comptes 336 rendus de l'Académie des sciences, pp.373-375, 1917.

W. Summers, Bacteriophage Therapy, Annual Review of Microbiology, vol.55, issue.1, pp.437-451, 2001.
DOI : 10.1146/annurev.micro.55.1.437

N. Chanishvili, Phage Therapy?History from Twort and d'Herelle Through Soviet Experience to Current Approaches, Adv Virus Res, vol.83, pp.3-40, 2012.
DOI : 10.1016/B978-0-12-394438-2.00001-3

D. Maura and L. Debarbieux, Bacteriophages as twenty-first century antibacterial tools for food and medicine, Applied Microbiology and Biotechnology, vol.34, issue.4, pp.851-859, 2011.
DOI : 10.1111/j.1749-4486.2009.01973.x
URL : https://hal.archives-ouvertes.fr/pasteur-01425532

K. Thiel, Old dogma, new tricks?21st Century phage therapy, Nature Biotechnology, vol.22, issue.1, pp.345-376, 2004.
DOI : 10.1038/nbt0104-31

L. Debarbieux, D. Leduc, and D. Maura, Bacteriophages can treat and prevent 350 pseudomonas aeruginosa lung infections, The Journal of infectious diseases, vol.201, pp.351-1096, 2010.

M. Henry, R. Lavigne, and L. Debarbieux, Predicting in vivo efficacy of therapeutic 353 bacteriophages used to treat pulmonary infections, Antimicrob Agents Chemother, vol.354, issue.57, pp.5961-5968, 2013.

E. Morello, E. Saussereau, D. Maura, M. Huerre, L. Touqui et al., Pulmonary Bacteriophage Therapy on Pseudomonas aeruginosa Cystic Fibrosis Strains: First Steps Towards Treatment and Prevention, PLoS ONE, vol.72, issue.Pt 10, p.16963, 2011.
DOI : 10.1371/journal.pone.0016963.t001
URL : https://hal.archives-ouvertes.fr/pasteur-01425539

J. Lu, C. Perng, S. Lee, and C. Wan, Use of pcr with universal primers and restriction 359 endonuclease digestions for detection and identification of common bacterial pathogens in 360 cerebrospinal fluid, Journal of Clinical Microbiology, vol.38, pp.2076-2080, 2000.

E. Mowat, S. Paterson, and J. Fothergill, Pseudomonas aeruginosa population diversity 362 and turnover in cystic fibrosis chronic infections, Am J Respir Crit Care Med, vol.183, pp.363-1674, 2011.
DOI : 10.1164/rccm.201009-1430oc

M. Workentine, C. Sibley, and B. Glezerson, Phenotypic heterogeneity of 365 pseudomonas aeruginosa populations in a cystic fibrosis patient, PLoS One, vol.8, pp.366-60225, 2013.

N. Hoyland-kroghsbo, R. Maerkedahl, and S. Svenningsen, A quorum-sensing-induced 368 bacteriophage defense mechanism, MBio, vol.4, pp.362-00312, 2013.
DOI : 10.1128/mbio.00362-12
URL : http://doi.org/10.1128/mbio.00362-12

L. Debarbieux, Bacterial sensing of bacteriophages in communities: the search for the Rosetta stone, Current Opinion in Microbiology, vol.20, pp.125-130, 2014.
DOI : 10.1016/j.mib.2014.05.015

J. Pirnay, D. Vos, D. Verbeken, and G. , The Phage Therapy Paradigm: Pr?t-?-Porter or Sur-mesure?, Pharmaceutical Research, vol.2, issue.4, pp.934-937, 2011.
DOI : 10.1038/nrmicro822

B. Chan, S. Abedon, and C. Loc-carrillo, Phage cocktails and the future of phage therapy, Future Microbiology, vol.8, issue.6, p.374
DOI : 10.2217/fmb.13.47